Fidelity Disruptive Medicine ETF
FMED
8 hedge funds and large institutions have $30.6M invested in Fidelity Disruptive Medicine ETF in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 8 → 8 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.24% less ownership
Funds ownership: 60.2% → 59.96% (-0.24%)
6% less capital invested
Capital invested by funds: $32.6M → $30.6M (-$1.98M)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
+$573K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$555 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$433K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$262K |
| 3 |
Morgan Stanley
New York
|
-$230 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Fidelity Investments
Boston,
Massachusetts
| $17.6M | -$262K | -10,841 | -1% |
|
|
2
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
| $12.5M | +$573K | +23,730 | +5% |
|
|
3
Jane Street
New York
| $491K | -$433K | -17,936 | -47% |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $3.9K | – | – | – |
|
|
CPBTD
5
Central Pacific Bank - Trust Division
Honolulu,
Hawaii
| $2.33K | – | – | – |
|
|
GEA
6
Glen Eagle Advisors
Kingston,
New Jersey
| $2.17K | – | – | – |
|
|
DF
7
Dunhill Financial
London,
United Kingdom
| $1.38K | – | – | – |
|
|
8
UBS Group
Zurich,
Switzerland
| $553 | +$555 | +23 | New |
|
|
9
Morgan Stanley
New York
| – | -$230 | -9 | Closed |
|
FMED Hedge Fund Activity: Q2 2024 in Review
8 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Fidelity Disruptive Medicine ETF (FMED) for Q2 2024, worth a combined $30.6M — down 6.1% from $32.6M a quarter earlier.
Fund positioning in FMED was balanced in Q2 2024: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was Wealth Enhancement Advisory Services, adding an estimated $573K. The largest seller was Jane Street, cutting an estimated $433K.
- 8 institutional investors held Fidelity Disruptive Medicine ETF (FMED) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $30.6M of Fidelity Disruptive Medicine ETF stock for Q2 2024, down 6.1% quarter-over-quarter.
- 1 fund opened new Fidelity Disruptive Medicine ETF positions in Q2 2024 and 1 closed out, a net change of 0 holders.
- The largest Fidelity Disruptive Medicine ETF buyer in Q2 2024 was Wealth Enhancement Advisory Services, an estimated $573K added.
- The largest Fidelity Disruptive Medicine ETF seller in Q2 2024 was Jane Street, an estimated $433K sold.
Based on aggregated 13F filings for Q2 2024.